We chatted to IronRidge Resources' CEO Vincent Mascolo who explains why the company has become a lithium explorer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSensyne Health. Share News (SENS)

Share Price Information for Sensyne Health. (SENS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 163.00
Bid: 160.00
Ask: 165.00
Change: -2.00 (-1.21%)
Spread: 5.00 (3.13%)
Open: 165.00
High: 165.00
Low: 163.00
Yest. Close: 165.00
SENS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

RNS Alerts are a premium feature

Login to your account

myTerminal is a premium feature

Login to your account

Don't have an account? Click here to register.

UK TRADING UPDATE SUMMARY: SourceBio Tips Jump In Virus Testing Demand

UK TRADING UPDATE SUMMARY: SourceBio Tips Jump In Virus Testing Demand

25 Nov 20 18:00

Sensyne Health signs five-year deal with NHS Hampshire Hospitals

(Sharecast News) - Clinical artificial intelligence (AI) company Sensyne Health has signed a five year non-exclusive strategic research agreement with Hampshire Hospitals NHS Foundation Trust, it announced on Wednesday.

25 Nov 20 15:07

IN BRIEF: Sensyne Health Achieves Five Million Patient Target

IN BRIEF: Sensyne Health Achieves Five Million Patient Target

16 Nov 20 11:41

UK EXECUTIVE CHANGE SUMMARY: Shake-Up Of Primorus Board Continues

UK EXECUTIVE CHANGE SUMMARY: Shake-Up Of Primorus Board Continues

13 Nov 20 14:43

Sensyne taps Derek Baird to lead North American expansion

(Sharecast News) - Clinical AI company Sensyne has tapped Derek Baird to take on the role of North American president as the group looks to advance its expansion into the region.

13 Nov 20 09:25

UK TRADING UPDATE SUMMARY: Sensyne App Used In Oxford Covid Study

UK TRADING UPDATE SUMMARY: Sensyne App Used In Oxford Covid Study

2 Nov 20 20:03

Sensyne Health app to be used in Covid-19 study

(Sharecast News) - Clinical artificial intelligence (AI) company Sensyne Health announced on Monday that its 'CVm-Health+' app is to be used by the University of Oxford in its 'FACTS' clinical study evaluating the feasibility and acceptability of new point-of-care tests for regular asymptomatic Covid-19 testing in the community.

2 Nov 20 09:27

Sensyne Health Partners With Microsoft To Develop AI Technology

Sensyne Health Partners With Microsoft To Develop AI Technology

28 Oct 20 15:33

IN BRIEF: Sensyne Partners With Milton Keynes University Hospital

IN BRIEF: Sensyne Partners With Milton Keynes University Hospital

26 Oct 20 17:43

IN BRIEF: Sensyne Health Partners Up With Bristol Myers Squibb

IN BRIEF: Sensyne Health Partners Up With Bristol Myers Squibb

23 Oct 20 16:37

UK Shareholder Meetings Calendar - Next 7 Days

UK Shareholder Meetings Calendar - Next 7 Days

23 Oct 20 16:04

Sensyne Health signs research collaboration deal with Bristol Myers Squibb

(Sharecast News) - Clinical artificial intelligence (AI) company Sensyne Health has signed a research collaboration agreement with Bristol Myers Squibb, it announced on Friday.

23 Oct 20 11:44

IN BRIEF: Sensyne Signs Data Sharing Deal With NHS Greater Glasgow

IN BRIEF: Sensyne Signs Data Sharing Deal With NHS Greater Glasgow

1 Oct 20 17:49

IN BRIEF: Sensyne Health To Provide Software For Covid Treatment Trial

IN BRIEF: Sensyne Health To Provide Software For Covid Treatment Trial

30 Sep 20 21:37

UK EARNINGS SUMMARY: Gama Aviation Interim Loss Widens As Revenue Down

UK EARNINGS SUMMARY: Gama Aviation Interim Loss Widens As Revenue Down

30 Sep 20 21:13

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.